S&P 500 at New Highs, Rate Cut, Tech Earnings & Buy BURL Stock - Free Lunch

On today’s episode of Free Lunch here at Zacks, Associate Stock Strategist Ben Rains dives into why the S&P 500 surged to a new high Monday, ahead of another possible interest rate cut. We then discuss tech earnings, including Google GOOGL and Apple AAPL, before we close with a look at why Burlington Stores, Inc. BURL is a Zacks Rank #1 (Strong Buy) right now.

The S&P 500 hit a record high Monday, for the first time in three months. The benchmark index is now up roughly 21% in 2019, but has cooled off over the last several months.

The climb comes ahead of another expected interest rate cut from the U.S. Federal Reserve. Therefore, Wall Street will be closely watching what Fed Chairman Jerome Powell says on Wednesday afternoon.

Investors are also more optimistic about the progress of the U.S.-China trade talks, with President Trump taking a positive tone Monday.

Meanwhile, earnings once again take center stage, with roughly 150 S&P 500 members set to report quarterly results this week, including an array of tech giants. Yesterday, shares of Google parent Alphabet GOOGL dipped after it posted lower-than-expected profit and other possibly worrisome results.

General Motors GM stock then climbed over 5% in morning trading Tuesday. Still, the automotive firm’s outlook appears rough after the recent strike.

Looking ahead, Advanced Micro Devices AMD is set to report its Q3 earnings results after the closing bell today, with the semiconductor firm up big in 2019 (also read: Spotlight on Tech Earnings).

More importantly, Apple reports its results after the closing bell Wednesday, as the iPhone giant sits at new highs. Facebook FB is also set to post its third-quarter financials tomorrow, roughly a week after Microsoft MSFT and Amazon AMZN

Tuesday’s episode of Free Lunch then closes why discount retailer Burlington is a Zack Ranks #1 (Strong Buy) stock heading into the holiday shopping season.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Amazon.com, Inc. (AMZN): Free Stock Analysis Report
Facebook, Inc. (FB): Free Stock Analysis Report
Alphabet Inc. (GOOGL): Free Stock Analysis Report
General Motors Company (GM): Free Stock Analysis Report
Apple Inc. (AAPL): Free Stock Analysis Report
Microsoft Corporation (MSFT): Free Stock Analysis Report
Advanced Micro Devices, Inc. (AMD): Free Stock Analysis Report
Burlington Stores, Inc. (BURL): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.